Clinical Study on Implicit Learning, Comorbidity and Stress Vulnerability in Chronic Functional Pain

August 2, 2006 updated by: Universitätsmedizin Mannheim

Implicit Learning, Comorbidity and Stress Vulnerability in Chronic Functional Pain Syndromes

The project investigates on the role of pain avoidance, comorbidity and stress response for the development of chronic somatic and visceral pain. We, the researchers at University Hospital Mannheim, assume that implicit operant learning of pain sensitization is a central mechanism of the process of pain becoming chronic, which is augmented by fear and by avoidance behaviour. Somatic and psychological comorbidity as well as stress factors are further promoting factors in chronic pain development.

Study Overview

Status

Unknown

Detailed Description

Study 1: Implicit operant learning of sensitization and habituation in an experimental heat pain model will be investigated and compared in healthy controls, chronic pain patients with fibromyalgia, with and w/o visceral pain.

Study 2: Functional imaging of implicit operant learning of sensitization and habituation in an experimental heat pain model (same subgroups as in study 1).

Study Type

Interventional

Enrollment

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Mannheim, Germany, D-68131
        • Recruiting
        • University of Mannheim - Otto-Selz-Institute
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Fibromyalgia according to American College of Rheumatology (ACR) criteria
  • Visceral hypersensitivity according to ROME criteria
  • Chronic pain according to International Association for the Study of Pain (IASP) criteria

Exclusion Criteria:

  • Abnormal quantitative sensory testing
  • Psychiatric or neurological anamnesis, except fear and depression
  • Acute major depression
  • Substance abuse

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Rupert Hoelzl, Prof. Dr. phil., University of Mannheim
  • Study Director: Hans-Joachim Bender, Prof. Dr. med. rer. nat., Universitätsmedizin Mannheim
  • Study Director: Lothar-Rudi Schad, Prof. Dr. rer. nat., German Cancer Research Centre Heidelberg

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2005

Study Completion

November 1, 2007

Study Registration Dates

First Submitted

September 13, 2005

First Submitted That Met QC Criteria

September 13, 2005

First Posted (Estimate)

September 22, 2005

Study Record Updates

Last Update Posted (Estimate)

August 3, 2006

Last Update Submitted That Met QC Criteria

August 2, 2006

Last Verified

September 1, 2005

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe